Michael T. McCaul sold United Therapeutics Corporation (NASDAQ: UTHR)
Michael T. McCaul (R-TX), a U.S. Representative, has disclosed 47 trades in United Therapeutics Corporation (UTHR) since 2021, 23 purchases and 24 sales, worth an estimated $3.1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Michael T. McCaul sold $50,001 - $100,000 of United Therapeutics Corporation (NASDAQ: UTHR) on August 12, 2025. Since that trade, UTHR is up +74.09% against the S&P 500 up +14.46%, an outperformance of +59.63%.
Across these filings, Michael T. McCaul has been a net seller of UTHR (a buy-to-sell ratio of 0.96). The most recent disclosed UTHR transaction shown was dated October 27, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Michael T. McCaul's UTHR trades vs the price
UTHR is up +74.09% since Michael T. McCaul sold on August 12, 2025, versus +14.46% for the S&P 500.
Performance since this trade
All Michael T. McCaul UTHR trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Michael T. McCaul & UTHR trading FAQ
Is it legal for Michael T. McCaul to trade United Therapeutics Corporation (UTHR) stock?
Yes. Members of Congress are allowed to trade individual stocks, including United Therapeutics Corporation (UTHR), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Michael T. McCaul sell UTHR?
Michael T. McCaul disclosed a sale of $50,001 - $100,000 of United Therapeutics Corporation (UTHR) on August 12, 2025, according to public STOCK Act filings.
How has UTHR performed since Michael T. McCaul's trade?
Since Michael T. McCaul sold UTHR on August 12, 2025, the stock is up +74.09%, versus +14.46% for the S&P 500 over the same period, an outperformance of +59.63%.
How many times has Michael T. McCaul traded UTHR?
Michael T. McCaul has disclosed 47 UTHR trades since 2021 (23 purchases and 24 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional UTHR trades?
Quantellect tracks every disclosed congressional trade in United Therapeutics Corporation (UTHR) on the United Therapeutics Corporation congressional trading page, which aggregates filings across all members of Congress.
Michael T. McCaul's UTHR tradesAll congressional filings for United Therapeutics CorporationMichael T. McCaul's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.